NPS Pharmaceuticals Inc

NPS Pharmaceuticals — Merger or Acquisition (May 2003)

8 slides from NPS Pharmaceuticals's merger presentation, May 2, 2003

  1. Slide 1: Science, Pipeline, Products: Creating a Biotechnology Leader

    Science, Pipeline, Products: Creating a Biotechnology Leader

  2. Slide 2: To Build a Sustainable Top-Tier Biotech Based On

    To Build a Sustainable Top-Tier Biotech Based On: • A deep, diversified and sustainable pipeline • A well defined pathway to profitability • A fully integrated infrastructure

  3. Slide 3: Platform Technologies, Pipeline and Commercialization

    Platform Technologies + PEGylation + PEG : Cytoxies + Inhaled NE Leupro Phase! Phase Il Preclinical Phase Ill + single-chain Antibodies Commercialization & Manufacturing + PEG-INTRON + ABELCET + ADAGEN + ONCASPAR * DEPOCYT NPS ™mm ENZON

  4. Slide 4: PREOS for the Treatment of Osteoporosis

    PREOS for the Treatment of Osteoporosis Proposed Indications and Usage

  5. Slide 5: TOP Study: Overview of Clinical Trial Design

    TOP Study Overview of Clinical Trial Design

  6. Slide 6: POWER Study: Overview of Clinical Trial Designs

    POWER Study Overview of Clinical Trial Designs

  7. Slide 7: OLES (Open Label Extension Study)

    \- + =O “sole ” _ OLES (Open Label Extension Study)

  8. Slide 8: Science, Pipeline, Products: Creating a Biotechnology Leader

    Science, Pipeline, Products: Creating a Biotechnology Leader

NPS Pharmaceuticals — Merger or Acquisition (May 2003) on 6ix